USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
A New Era in Human Health to Resolve Unmet Medical Needs
This research service focuses on the 4 broad segments of the regenerative medicine market, namely cell therapy, gene therapy, tissue engineering, and small molecules and biologics. A detailed overview of the cell therapy segment, including the major commercialised products and products in development, has been provided. Additionally, key clinical milestones, timelines of key clinical events, key companies to watch, and a strategic partnership assessment in the global regenerative market have been included. An overview of the other segments—gene therapy, tissue engineering, and small molecules and biologics—has also been provided.
Executive Summary
Executive Summary (continued)
Regenerative Medicine Market—Game-changing Strategies
Methodology and Scope
Introduction
Introduction (continued)
Introduction (continued)
Market Overview—Segmentation
Market Overview—Cell Therapy (CT)Segment
Market Overview—Cell Therapy (CT)Segment (continued)
Market Overview—Cell Therapy (CT)Segment (continued)
Market Overview—Cell Therapy (CT)Segment (continued)
Market Overview—Gene Therapy (GT) Segment
Market Overview—Tissue Engineering (TE) Segment
Market Overview—Small Molecules and Biologics Segment
Cell Therapy—Competitive Landscape of Marketed Products
Cell Therapy—Competitive Landscape of Products in Development
Cell Therapy—Market Segmentation
Cell Therapy—Marketed Products Synopsis
Cell Therapy—Marketed Products Synopsis (continued)
Cell Therapy—Marketed Products Synopsis (continued)
Cell Therapy—Marketed Products Synopsis (continued)
Product Dashboard—Apligraf (Organogenesis)
Product Dashboard—GINTUIT (Organogenesis)
Product Dashboard—Provenge (Dendreon)
Product Dashboard—Grafix (Osiris Therapeutics)
Product Dashboard—Dermagraft (Shire)
Product Dashboard—Osteocel Plus (NuVasive)
Product Dashboard—ReCell Spray-On Skin (Avita Medical)
Product Dashboard—Trinity Evolution (Orthofix)
Product Dashboard—BioDfactor (BioD, LLC)
Product Dashboard—BioDfence (BioD, LLC)
Cell Therapy—Pipeline Synopsis
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy Regenerative Medicine Segment—Major On-going/Recently Completed Clinical Trials
Cell Therapy Regenerative Medicine Segment—Major On-going/Recently Completed Clinical Trials (continued)
Cell Therapy Regenerative Medicine Segment—Major On-going/Recently Completed Clinical Trials (continued)
Cell Therapy Regenerative Medicine Segment—Major On-going/Recently Completed Clinical Trials (continued)
Cell Therapy Regenerative Medicine Segment—Major On-going/Recently Completed Clinical Trials (continued)
Cell Therapy—Pipeline Breakdown
Company—Aastrom Biosciences, Inc.
Company—Advanced Cell Technology, Inc.
Company—Aldagen, Inc. (Acquired by Cytomedix)
Company—Athersys, Inc.
Company—Celgene Cellular Therapeutics
Company—Cellerant Therapeutics, Inc.
Company—Gamida Cell Ltd.
Company—Garnet BioTherapeutics
Company—Histogenics
Company—Mesoblast Ltd.
Company—Neuralstem, Inc.
Company—Osiris Therapeutics, Inc.
Company—Pluristem Therapeutics, Inc.
Company—SanBio, Inc.
Company—StemCells, Inc.
Company—TCA Cellular Therapy, LLC
Company—TiGenix NV
Gene Therapy Overview
Gene Therapy Overview (continued)
Gene Therapy Overview (continued)
Key Company to Watch—Juventas Therapeutics Inc.
Tissue Engineering Overview
Tissue Engineering Overview (continued)
Tissue Engineering Overview (continued)
Tissue Engineering Overview (continued)
Tissue Engineering Overview (continued)
Small Molecules and Biologics Overview
Small Molecules and Biologics Overview (continued)
Cardiovascular Disease (CVD) Regenerative Medicine Market
Cardiovascular Disease (CVD) Regenerative Medicine Market (continued)
Cardiovascular Disease (CVD) Regenerative Medicine Market (continued)
Vascular Disease Regenerative Medicine Market
Vascular Disease Regenerative Medicine Market (continued)
Non-Healing Wounds Regenerative Medicine Market
Non-Healing Wounds Regenerative Medicine Market (continued)
Spinal Cord Injury Regenerative Medicine Market
Spinal Cord Injury Regenerative Medicine Market (continued)
Spinal Cord Injury Regenerative Medicine Market (continued)
Alzheimer’s Disease Regenerative Medicine Market
Alzheimer’s Disease Regenerative Medicine Market (continued)
Parkinson’s Disease (PD) Regenerative Medicine Market
Musculoskeletal Regenerative Medicine Market
Musculoskeletal Regenerative Medicine Market (continued)
Musculoskeletal Regenerative Medicine Market (continued)
Autoimmune Disorders Regenerative Medicine Market
Autoimmune Disorders Regenerative Medicine Market (continued)
Autoimmune Disorders Regenerative Medicine Market (continued)
Stroke Regenerative Medicine Market
Stroke Regenerative Medicine Market (continued)
Diabetes Regenerative Medicine Market
Diabetes Regenerative Medicine Market (continued)
Ocular Diseases Regenerative Medicine Market
Ocular Diseases Regenerative Medicine Market (continued)
Regenerative Medicine Market—Timeline of Key Events
Regenerative Medicine Market—Timeline of Key Events (continued)
Regenerative Medicine Market—Timeline of Key Events (continued)
Regenerative Medicine Market—Timeline of Key Events (continued)
Regenerative Medicine Market—Merger, Acquisition, and Partnership Assessment
Regenerative Medicine Market—Merger, Acquisition, and Partnership Assessment (continued)
Regenerative Medicine Market—Merger, Acquisition, and Partnership Assessment (continued)
Regenerative Medicine Market—Merger, Acquisition, and Partnership Assessment (continued)
Regenerative Medicine Market—Funding Scenario
Regenerative Medicine Market—Funding Scenario (continued)
Regenerative Medicine Market—Funding Scenario (continued)
Regenerative Medicine Market—Funding Scenario (continued)
Conclusions and Recommendations
Legal Disclaimer
Human Embryonic Stem Cells Overview
Mesenchymal Stem Cells Overview
Neural Stem Cells Overview
Induced Pluripotent Stem Cells Overview
Stem Cell Types in Development
List of Abbreviations
The Frost & Sullivan Story
Value Proposition
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related industry research
17 Sep 2026 | Asia Pacific | Frost Radar
Frost Radar™: Facility Management in Malaysia, 2026
Malaysia's facility management (FM) market is transitioning from labor-intensive, compliance-driven service delivery to technology-enabled, outcome-oriented, and sustainability-integrated operating models. Competitive differentiation increasingly depends on providers’ ability to combine integrated F...
17 Sep 2026 | Global | Market Research
Growth Opportunities in the Western Europe Consumer eSIM Market, 2026–2029
The consumer eSIM market in Western Europe is growing steadily, supported by the rising availability of eSIM-capable devices, particularly smartphones, and expanding travel-related use cases. However, commercialization has yet to translate into mass adoption. Despite Apple’s global launch of an eSIM...
17 Sep 2026 | Asia Pacific | Frost Radar
Frost Radar™: ASEAN Warehouse Automation System Providers, 2026
Warehouse automation has moved from a discretionary capital project to a core operating capability. ASEAN operators are redesigning fulfillment networks around smaller orders, shorter delivery windows, broader stock keeping unit (SKU) ranges, and sharper demand volatility. Manual operations remain v...
16 Sep 2026 | North America | Customer Research
US Automotive Technicians’ Choice Survey, 2025
The 2025 US Automotive Technicians’ Choice study is an insightful voice-of-customer survey that highlights the tool preferences of automotive aftermarket service technicians. The survey of 400 automotive technicians across the United States used a combination of computer-assisted telephone and compu...
16 Sep 2026 | Global | Market Research
Apple Performance Tracker, Q1 2026
This Frost & Sullivan tracker provides metrics on Apple's quarterly performance (for both unit sales and revenues) for iPads, iPhones, Macs, and other products, such as iPods, Apple TVs, Beats Electronics, and Apple-branded and third-party accessories. It includes historical quarterly data for all t...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Aiswariya Chidambaram |
| WIP Number | MA1E-01-00-00-00 |
| Is Prebook | No |
Global Regenerative Medicine Market
$3,950.00
Special Price $2,962.50 save 25 %